大灶性骨髓瘤诊断为多发性骨髓瘤一例 - betway必威登陆网址

国际肿瘤学杂志››2020,Vol. 47››Issue (3): 190-192.doi:10.3760/cma.j.issn.1673-422X.2020.03.012

• 病例报道 •上一篇

大灶性骨髓瘤诊断为多发性骨髓瘤一例

张菡偌^1,², 白海²()

¹甘肃中医药大学研究生院,兰州 730000;
²联勤保障部队第九四〇医院血液病专科中心,兰州 730050

收稿日期:2020-01-06修回日期:2020-01-30出版日期:2020-03-08发布日期:2020-05-27
通讯作者:白海 E-mail:baihai@tom.com

Received:2020-01-06Revised:2020-01-30Online:2020-03-08Published:2020-05-27

摘要/Abstract

摘要：

大灶性骨髓瘤是一种非常罕见的浆细胞瘤,目前对其生物学行为认识有限,易误诊为经典多发性骨髓瘤及其他髓外浆细胞瘤。现报道1例大灶性骨髓瘤的临床诊治经过,并对其临床特点及鉴别诊断进行探讨。

张菡偌, 白海. 大灶性骨髓瘤诊断为多发性骨髓瘤一例[J]. 国际肿瘤学杂志, 2020, 47(3): 190-192.

图/表3

参考文献7

[1]	Caers J, Paiva B, Zamagni E , et al. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel[J]. J Hematol Oncol, 2018,11(1):10. DOI: 10.1186/s13045-017-0549-1. doi:10.1186/s13045-017-0549-1
[2]	Hughes M, Doig A, Soutar R . Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns[J]. Br J Haematol, 2007,137(5):486-487. DOI: 10.1111/j.1365-2141.2007.06599.x. doi:10.1111/bjh.2007.137.issue-5
[3]	Chen LP, Sun TH, Hsieh PP , et al. Diagnostic pitfalls of nonsecretory myeloma manifesting as multiple foci of periosseous plasmacytomas[J]. J Chin Med Assoc, 2011,74(10):464-468. DOI: 10.1016/j.jcma.2011.08.018. doi:10.1016/j.jcma.2011.08.018
[4]	Tsang RW, Campbell BA, Goda JS , et al. Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the international lymphoma radiation oncology group[J]. Int J Radiat Oncol Biol Phys, 2018,101(4):794-808. DOI: 10.1016/j.ijrobp.2018.05.009. doi:10.1016/j.ijrobp.2018.05.009
[5]	Mignot F, Schernberg A, Arsène Henry A , et al. Solitary plasmacytoma: lenalidomide-dexamethasone combined with radiation therapy: clinical outcomes[J]. Int J Radiat Oncol Biol Phys, 2020,106(3):589-596. DOI: 10.1016/j.ijrobp.2019.10.043. doi:10.1016/j.ijrobp.2019.10.043
[6]	Katodritou E, Kastritis E, Gatt M , et al. Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the novel therapeutic era: a study of the Greco-Israeli Collaborative Myeloma Working Group[J]. Am J Hematol, 2020, In press. DOI: 10.1002/ajh.25755.
[7]	Goranova Marinova V, Yaneva M, Deneva T , et al. Multiple myeloma with advanced bone disease and low tumor burden-different clinical presentation but similar outcome after bortezomib-based therapy and radiotherapy[J]. Acta Clin Croat, 2017,56(2):262-268. DOI: 10.20471/acc.2017.56.02.09.

相关文章15

编辑推荐

Metrics

本文评价